Very frustrating particularly as many of the uranium mining projects (particularly explorers) are unlikely to be in production (after all the regulation/environmental hurdles they need to jump through) for between 6 and 8 years (when PLEF should be built) and GLE will also be in a position to also address the LEU, LEU+ and HALEU markets (with a world beating efficiency/selective separation "edge"), does not have HF6 conversion costs and SLX gets a 7% to 12% royalty. That's also not forgetting ha SLX are in the ZS Si market (now not just selling to quantum computer (in 2023) but also now the general semi-conductor market - see latest presentation) and will also get cREO royalties from IQE with a base royalty of 3%.
Hopefully these unique selling points will at some time dawn on fund managers; a good start would be for ETF's (URA and URMN) to include SLX in their portfolio. Maybe this will happen when Sprott take over URMN (soon) they currently have low market cap miner like Toro (MC A$74m), PEN (MC A$214m) & VMY (MC A$238M) on in their portfolio - SLX s now larger - MC A$246m - why aren't we in the URMN ETF portfolio? URA has Centrus (and VMY & PEN) in its portfolio - I can' see why we are not there? It would likely be a big re-rate once SLX is recogniised as a player in the Uranium ETF's rather than just a small "tech" ETF
- Forums
- ASX - By Stock
- SLX
- Uranium Price
Uranium Price, page-12
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SLX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$5.16 |
Change
-0.020(0.39%) |
Mkt cap ! $1.212B |
Open | High | Low | Value | Volume |
$5.18 | $5.20 | $5.10 | $930.9K | 180.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
31 | 3942 | $5.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.16 | 1602 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
26 | 3417 | 5.150 |
13 | 4621 | 5.140 |
17 | 6391 | 5.130 |
17 | 13890 | 5.120 |
11 | 11205 | 5.110 |
Price($) | Vol. | No. |
---|---|---|
5.160 | 1690 | 14 |
5.170 | 2611 | 8 |
5.180 | 7891 | 9 |
5.190 | 9324 | 9 |
5.200 | 28004 | 8 |
Last trade - 15.48pm 15/07/2024 (20 minute delay) ? |
Featured News
SLX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online